These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6183593)

  • 1. High frequency of antigenic variants among naturally occurring human Coxsackie B4 virus isolates identified by monoclonal antibodies.
    Prabhakar BS; Haspel MV; McClintock PR; Notkins AL
    Nature; 1982 Nov; 300(5890):374-6. PubMed ID: 6183593
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of conserved and nonconserved epitopes on Coxsackievirus B4: frequency of antigenic change.
    Prabhakar BS; Menegus MA; Notkins AL
    Virology; 1985 Oct; 146(2):302-6. PubMed ID: 2413617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies for study of antigenic variation in coxsackievirus type B4: association of antigenic determinants with myocarditic properties of the virus.
    Cao Y; Schnurr DP; Schmidt NJ
    J Gen Virol; 1984 May; 65 ( Pt 5)():925-32. PubMed ID: 6202831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralization epitope diversity of coxsackievirus B4 isolates detected by monoclonal antibodies.
    Webb SR; Kearse KP; Foulke CL; Hartig PC; Prabhakar BS
    J Med Virol; 1986 Sep; 20(1):9-15. PubMed ID: 2428930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The isolation and characteristics of monoclonal antibodies to the structural proteins of Coxsackie B5 virus].
    Boss A; Piirsoo A
    Vopr Virusol; 1994; 39(2):80-2. PubMed ID: 8017060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralization kinetic analysis of echovirus 30 and coxsackievirus B4 strains revealed little antigenic variation amongst the echovirus strains.
    Ash P; Leong WA; Kennett ML; Schnagl RD
    Aust J Exp Biol Med Sci; 1985 Apr; 63 ( Pt 2)():219-21. PubMed ID: 2994613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence homology of the diabetes-associated autoantigen glutamate decarboxylase with coxsackie B4-2C protein and heat shock protein 60 mediates no molecular mimicry of autoantibodies.
    Richter W; Mertens T; Schoel B; Muir P; Ritzkowsky A; Scherbaum WA; Boehm BO
    J Exp Med; 1994 Aug; 180(2):721-6. PubMed ID: 7913951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of coxsackievirus B4 variants with monoclonal antibodies results in attenuation.
    Prabhakar BS; Srinivasappa J; Ray U
    J Gen Virol; 1987 Mar; 68 ( Pt 3)():865-9. PubMed ID: 3029310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of antigenic determinants of the adenine-nucleotide translocator and coxsackie B3 virus with synthetic peptides: use for the diagnosis of viral heart disease.
    Schwimmbeck PL; Schwimmbeck NK; Schultheiss HP; Strauer BE
    Clin Immunol Immunopathol; 1993 Aug; 68(2):135-40. PubMed ID: 7689426
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of a putative shared epitope between Coxsackie virus B4 and alpha cardiac myosin heavy chain.
    Beisel KW; Srinivasappa J; Prabhakar BS
    Clin Exp Immunol; 1991 Oct; 86(1):49-55. PubMed ID: 1717188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A point mutation in VP1 of coxsackievirus B4 alters antigenicity.
    Halim S; Ramsingh AI
    Virology; 2000 Mar; 269(1):86-94. PubMed ID: 10725201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of serotype-specific and nonserotype-specific B-cell epitopes of coxsackie B virus using synthetic peptides.
    Haarmann CM; Schwimmbeck PL; Mertens T; Schultheiss HP; Strauer BE
    Virology; 1994 May; 200(2):381-9. PubMed ID: 7513917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the CD8-positive subset of T cells in proliferative responses to soluble antigens. II. CD8-positive cells are not responsible for DR-associated differences in responsiveness to mumps and Coxsackie B4.
    Bruserud O; Sollid L; Gaudernack G; Thorsby E
    Scand J Immunol; 1986 Apr; 23(4):469-73. PubMed ID: 3010444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cuban epidemic neuropathy. II. The antigenic characteristics of the viral isolates].
    Más Lago P; Guzmán MG; Muné M; Resik S; Alvarez M
    Rev Cubana Med Trop; 1995; 47(1):16-20. PubMed ID: 9805061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis of antigenic variation in the picornaviruses.
    Brown F
    Ann N Y Acad Sci; 1980; 354():202-18. PubMed ID: 6164329
    [No Abstract]   [Full Text] [Related]  

  • 16. Antigenic competition between dengue and Coxsackie viruses for presentation to B cells by macrophages.
    Rizvi N; Chaturvedi UC; Mathur A
    Int J Exp Pathol; 1990 Dec; 71(6):761-70. PubMed ID: 2177622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Coxsackievirus 2A
    Laitinen OH; Svedin E; Kapell S; Hankaniemi MM; Larsson PG; Domsgen E; Stone VM; Määttä JAE; Hyöty H; Hytönen VP; Flodström-Tullberg M
    J Virol Methods; 2018 May; 255():29-37. PubMed ID: 29425680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diabetogenic properties of Coxsackie A13 and Coxsackie B4 viruses in experimental infection in mice].
    Bocharov EF; Shorin IuP; Solodovnikova IA; Kazarian LS; Seliatitskaia VG
    Vopr Virusol; 1988; 33(4):469-74. PubMed ID: 2848368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of the antigenic variation in poliovirus type 1. Selection and analysis of variant strains with monoclonal antibodies by neutralization.
    Thibodeau L; Lacroix M; Lecomte J; Fauvel M
    Dev Biol Stand; 1984; 57():157-63. PubMed ID: 6084606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.